HLB bioStep Co.,Ltd. (KOSDAQ:278650)
1,566.00
+4.00 (0.26%)
At close: Jun 9, 2025, 3:30 PM KST
HLB bioStep Revenue
HLB bioStep had revenue of 13.58B KRW in the quarter ending March 31, 2025, with 17.39% growth. This brings the company's revenue in the last twelve months to 60.18B, up 18.96% year-over-year. In the year 2024, HLB bioStep had annual revenue of 58.17B with 10.14% growth.
Revenue (ttm)
60.18B
Revenue Growth
+18.96%
P/S Ratio
2.28
Revenue / Employee
401.20M
Employees
150
Market Cap
137.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 58.17B | 5.35B | 10.14% |
Dec 31, 2023 | 52.81B | -33.46B | -38.79% |
Dec 31, 2022 | 86.28B | 21.87B | 33.96% |
Dec 31, 2021 | 64.40B | 5.88B | 10.05% |
Dec 31, 2020 | 58.52B | 12.48B | 27.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hyundai Motor Company | 178.98T |
Hanwha Aerospace | 15.28T |
Kia Corporation | 109.25T |
KB Financial Group | 14.93T |